This review emphasizes the latest developments in bioprinted scaffolds in tissue engineering, with a focus on their biomimetic applications. The accelerated pace of development of 3D bioprinting technologies has transformed the ability to fabricate scaffolds with the potential to replicate the structure and function of native tissues. Bioprinting methods such as inkjet, extrusion-based, laser-assisted, and digital light processing (DLP) approaches have the potential to fabricate complex, multi-material structures with high precision in geometry, material composition, and cellular microenvironments. Incorporating biomimetic design principles to replicate the mechanical and biological behaviors of native tissues has been of major research interest. Scaffold geometries that support cell adhesion, growth, and differentiation essential for tissue regeneration are mainly of particular interest. The review also deals with the development of bioink, with an emphasis on the utilization of natural, synthetic, and composite materials for enhanced scaffold stability, printability, and biocompatibility. Rheological characteristics, cell viability, and the utilization of stimuli-responsive bioinks are also discussed in detail. Their utilization in bone, cartilage, skin, neural, and cardiovascular tissue engineering demonstrates the versatility of bioprinted scaffolds. Despite the significant advancements, there are still challenges that include achieving efficient vascularization, long-term integration with host tissues, and scalability. The review concludes by underlining future trends such as 4D bioprinting, artificial intelligence-augmented scaffold design, and the regulatory and ethical implications involved in clinical translation. By considering these challenges in detail, this review provides insight into the future of bioprinted scaffolds in regenerative medicine.

Background: In the past two decades, extensive research has focused on lipid nanocarriers for targeted drug delivery to treat various diseases. Among these, inflammatory conditions pose a formidable challenge in modern healthcare, encompassing a diverse spectrum from autoimmune disorders to chronic inflammation. Effective therapeutic interventions necessitate the development of targeted and efficient delivery systems to address the complexities associated with drug administration. Purpose: This review highlights different approaches of lipid-based nanocarriers to target various inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease (IBD), psoriasis, asthma, and chronic obstructive pulmonary disease (COPD). It focuses on the advancements made in Lipid Nano-Carriers (LNC) with a special emphasis on their inherent safety, lower stability costs, and enhanced encapsulation efficiency. Methods: Recent literature has been surveyed from PUBMED, GOOGLE SCHOLAR, etc., like search engines, for summarising detailed ongoing developments in the field of lipid nanocarriers for inflammatory diseases, which could prove to be a novel carrier for efficient drug delivery with special emphasis on surface modifications, formulations, pharmacokinetics, and efficacy. Conclusion: This review emphasizes recent researches in the field of lipid-based nano formulations for managing inflammatory disease, as well as extensive discussion on their limitations and future prospective.

Background: Depression and anxiety are prevalent psychiatric disorders in the modern era, often attributed to the alterations in signalling neurotransmitters or the release of biogenic amines characterized by changes in consciousness, psychomotor functions, and emotional disturbances. Purpose: Several antidepressant drugs are available; they may cause irreversible adverse effects. Therefore, exploring herbal remedies as an alternative therapy holds potential benefits. Macrotyloma uniflorum and Clitoria ternatea are among the plants traditionally utilized for their anti-depression activity. Method: This study aims to compare the antidepressant activity of the methanolic extracts of M. uniflorum and C. ternatea leaves. Their phytochemical compositions were analysed, and antioxidant activities were evaluated using DPPH and Superoxide radical scavenging assays. Results: The outcomes of phytochemical screening indicated the presence of secondary metabolites in both extracts, including alkaloids, saponins, glycosides, steroids, flavonoids, phenols, terpenoids and tannins. The antioxidant assays indicated significant antioxidant potential in both M. uniflorum and C. ternatea extracts. Various biochemical assays, behavioural studies, and histopathological evaluations were conducted using a toluene-induced mice model. Conclusion: The behavioural study and biochemical estimations confirmed the antidepressant potential of both extracts. However, the M. uniflorum extract exhibited better efficacy in alleviating depressive symptoms. In light of future perspectives, it would be valuable to isolate and identify the specific compounds facilitating a more targeted pharmacological approach for depression pharmacotherapy.